Anne Mette Koch will defend her PhD thesis on Thursday January 28, 2016
Trial lecture: Thursday January 28 2016, 09:15
Topic: “Fra overvåking til redusert infeksjonsbyrde: Hvordan bør vi implementere kunnskap om sykdomsbyrde fra infeksjonsovervåking i sykehjem og sykehus, og hvordan kan vi måle effekten?”
Place: Auditorium 2, Bygg for biologiske basalfag, Jonas Lies vei 91
Public defense: Thursday January 28 2016 11:15
Place: Auditorium 2Bygg for biologiske basalfag, Jonas Lies vei 91
Title of dissertation: “Lessons learned from infection surveillance: Occurrence, risk factors and consequences of healthcare-associated infections in hospitals and long-term care facilities”
1st opponent:Avdelingsdirektør Bjørn Iversen, Folkehelseinstituttet
2nd opponent:Professor Guri Rørtveit, Universitetet i Bergen
Press release (in Norwegian)
Based on last week’s search for “Department of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to email@example.com.
Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.
Scand J Rheumatol. 2016 Jan 15:1-8.
Here you will find this weeks application deadlines: Continue reading
At this time of the year the departments are preparing for their reports to the faculty – and I then particularly think about the PhD training and research reports. These are important documents that the faculty uses to inform and update the University centrally on their performance and long-term strategies. These reports therefore contribute to communicate the departments’ thoughts, desires and needs to UiB. Is there anything new to report or is this just the same litany as last year? Yes, there are actually new elements that have been added. For instance, what has the department accomplished when it comes to internationalization, career planning and publication? Although publications are always metioned, it will now be put more in focus. It will be especially important for Department of Clinical Science to focus on publishing, since we have had a decrease in the number of publications since 2013. But we’ve had a very good progress on external funding – not least the EU and NFR – which hopefully will result in increased publishing further on.
This is my last editor of “K2Nytt” since I after a 3-year appointment as Research Director / Deputy Head of Research at Department of Clinical Science is going to focus on other tasks. I will therefore take this opportunity to thank you all for three rewarding and exciting years – for good cooperation within the management team, the Research Committee, with the PhD coordinator and everyone I have been in contact with. Besides my responsibility as head of Broegelmann Research Laboratory and the research group for immunology and rheumatology, I have also been involved in several inspiring and stimulating working groups with direct relevance for PhD training and research. As I have previously mentioned in my editorials, I have participated in the OU-7 report on PhD training at UiB, the report on supervisor training at UiB (delivered to the university administration before Christmas), and I have also taken part of the UHR appointed national career group, and not least the ongoing international work carried out within ORPHEUS. So I will have enough to do also in the future.
In connection with an update of WordPress the theme K2Nytt used as layout was removed. We are working on a new layout, and in the meantime K2Nytt appears in a temporary layout.
We present Tina Kamceva, PhD in physical chemistry. Tina joined the Department as Chief Engineer of Research Group G4- Asbjørn Svardal this January.
If you want to say hello, you can find her on the 9th floor in the lab building.
There are new and stricter rules for mobile phone covered by UiB. See attached letter (in Norwegian).